The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 140.00
Bid: 135.00
Ask: 145.00
Change: 12.50 (9.80%)
Spread: 10.00 (7.407%)
Open: 127.50
High: 140.00
Low: 127.50
Prev. Close: 127.50
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Quiz sales fall, names new CEO; Byotrol eyes AIM exit

Wed, 03rd Apr 2024 10:59

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Quiz PLC - Glasgow, Scotland-based fashion retailer - Chief Executive Officer Tarak Ramzan, who also founded Quiz and is largest shareholder, steps down from post. He takes on a non-executive director role. Chief Commercial Officer Sheraz Ramzan takes over as CEO immediately. "He will implement a turnaround strategy to recalibrate the Quiz brand, its product offering, and reconnect with consumers with the aim of moving the business back into profitable growth," the firm says. Non-Executive Chair Peter Cowgill to take a "more active role in supporting the Company through to conclusion of the ongoing review of strategic options". Cowgill was formerly executive chair of JD Sports Fashion PLC. Quiz adds: "In addition to these changes, the board continues to search for at least one additional independent non-executive director following Charlotte O'Sullivan's departure in November 2023 and will provide an update in due course." Quiz says UK sales continue to be "impacted by subdued levels of traffic both in-store and online". Between the start of 2024 up to February 29, sales fell 9% on-year to GBP8.6 million. Sales since the start of the financial year on April 1 until the end of February fell 12% annually to GBP74.4 million. Expects revenue and a pretax loss in line with expectations. Quiz adds: "The group is taking a number of positive steps to counter the impact of the declining revenues including targeting cost savings for the forthcoming year, eliminating loss making activities, reviewing operational efficiencies and optimising its product offer."

----------

Byotrol PLC - manufacturer of biocidal and antimicrobial cleaning products - Proposes cancellation of AIM listing and re-registration as private company, as its directors conclude that it is no longer financially viable to continue trading shares publicly. In a trading update, Byotrol says it expects product sales in the financial year ending Sunday to be in line with expectations at GBP3.9 million, up 5.4% from GBP3.7 million a year earlier on a like-for-like basis, excluding discontinued items. It now expects headline loss before interest, tax, depreciation and amortisation, before exceptionals, of GBP1.0 million, widening from GBP700,000 a year earlier.

----------

Molecular Energies PLC - North, Central and South America-focused oil and gas company - Proposes cancelling its listing on AIM in London, saying it can no longer justify the "disproportionately high costs"."I take no joy in recommending the cancellation of trading in Molecular's shares on AIM and know that this proposal will impact many shareholders. However, the primary benefits of being listed are to avail oneself of access to capital, the ability to utilise one's shares as currency and enjoying the reputational boost of being on the London Stock Exchange. Molecular no longer receives any of those benefits," says Chair Peter Levine. "As a group its interests are best served by turning to the private arena where Molecular can regenerate away from the microscope and constraints of the public markets yet avail itself of funding and exit opportunities in some ways more flexible and abundant than remaining as a small public company on the London market." Reconsiders merit of float of 75% owned carbon removal and mitigation subsidiary Green House Capital Group PLC but believes the IPO is not in the "best interests of the company or its shareholders at the current time". Shareholders to vote on Molecular's delisting proposal on April 15. The last day of dealings could be April 26.

----------

Hellenic Dynamics PLC - Cultivator and supplier of medical cannabis products with a facility in northern Greece - Riverfort Securities Ltd subscribes for shares in Hellenic in order to discharge part of an outstanding loan to the medical cannabis cultivator. The loan and accrued interest of GBP90,757 will be settled through the issue of 3.9 million shares at 2.34 pence each.

----------

Provexis PLC - Reading, England-based producer of heart-health functional food ingredient Fruitflow - Agrees purchase of further batch of Fruitflow II SD inventory from dsm-firmenich, to satisfy increasing demand. Purchase totals GBP341,000. Provexis issues 45.1 million new shares, worth GBP293,304, to dsm-firmenich to part satisfy purchase. Rest of consideration to be satisfied in cash. "The Company is also pleased to confirm that it has now completed the setup of a new Irish subsidiary company, Provexis Ireland Ltd, which will facilitate tariff free sales of Fruitflow to customers in the EU," Provexis adds.

----------

Faron Pharmaceuticals Ltd - Turku, Finland-based drug discovery and development company - Says in advanced talks with "various investors in order to secure immediate funding". "The company's current cash balance is sufficient to allow the Faron to continue its operations into April 2024, however whilst the company is in advanced negotiations to complete the remaining bridge financing of approximately EUR5 million shortly, the Company notes that there is no guarantee that the required funds will be raised," Faron adds.

----------

Real Estate Credit Investments Ltd - investor in European real estate credit markets - Plans further buyback programme which runs to September 30 worth GBP10.0 million in total. Initial buyback of GBP5.0 million had expired at end of March.

----------

Coro Energy PLC - South East Asian-focused energy company - Notes announcement from Conrad Asia Energy Ltd, holder of 77% interest in Duyung production sharing contract in offshore Indonesia. Conrad announces gas sales agreement for domestic portion of Mako gas to Indonesia's national oil company PT Pertamina. Coro has a 15% stake in the production sharing pact. Empyrean Energy PLC, with an 8.5% interest, also notes the announcement. Both also note a new reserves report for Duyung. Revised estimate of best case recoverable dry gas as of December 31 stands at 329 billion cubic feet. This is a 10% decrease from a July 2022 report.

----------

San Leon Energy PLC - Nigeria-focused oil and gas production, development and exploration company - Notes Decklar Petroleum Ltd announces Crude oil volumes from Oza field through Trans Niger pipeline to Bonny export terminal. Just over 18,400 barrels of crude oil transported so far in 2024. "Decklar and Millenium have injected a total of 34,600 barrels of crude oil into the Bonny Export Terminal from commencement of TNP pipeline operation in late 2023," San Leon adds. It has an 11% shareholding in Decklar.

----------

Global Connectivity PLC - Isle of Man-based broadband provider to rural areas in the UK - Changes terms of warrants attached to shares subscribed for at time of initial public offering back in October 2020. Extends warrant exercise period by two years to April 20, 2026 for 100.0 million investor warrants and cuts exercise price to 1.5p per share. For 1.6 million adviser warrants, which had been due to expire in October 2025, the exercise period is also extended to April 2026 and also at 1.5p per share. Executive Chair Keith Harris says: "In recognition of the support offered to us by investors and other stakeholders at the stage of our initial listing, your board has decided to improve the terms of the warrants issued at that time as described above. We continue to explore other potential investments in companies in the communication services space and technologies that enhance connectivity."

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
15 Apr 2024 10:58

Faron Pharmaceuticals reappoints former finance chief on interim basis

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it appointed a new interim chief financial officer to replace the outgoing James O'Brien.

Read more
15 Apr 2024 09:36

Faron Pharmaceuticals CFO stands down

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals revealed on Monday that chief financial officer James O'Brien would be leaving the group to "pursue another career opportunity".

Read more
8 Apr 2024 11:50

UPDATE: Faron Pharmaceuticals promotes COO to CEO as father retires

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it will promote its chief operating officer to chief executive to replace his father, the company's founder.

Read more
8 Apr 2024 11:28

Faron Pharmaceuticals promotes COO to CEO as founder steps back

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it will promote its chief operating officer to chief executive to replace the company's founder.

Read more
8 Apr 2024 09:17

Faron Pharmaceuticals taps Juho Jalkanen for CEO

(Sharecast News) - Biopharmaceutical company Faron Pharmaceuticals named Dr Juho Jalkanen as its next chief executive officer on Monday.

Read more
4 Apr 2024 11:58

Faron Pharmaceuticals secures funding to deliver next "milestones"

(Alliance News) - Faron Pharmaceuticals Ltd on Thursday said it has successfully raised funds to support the phase two study of its bexmarilimab cancer treatment.

Read more
2 Apr 2024 13:22

UK shareholder meetings calendar - next 7 days

Wednesday 3 April 
Downing Strategic Micro-Cap Investment Trust PLCGM re approval of B share scheme
Quantum Exponential Group PLCGM re delisting or potential investment in company
Thursday 4 April 
Rio Tinto PLCAGM
Scottish American Investment Co PLCAGM
TheWorks.co.uk PLCGM re Main Market delisting and AIM admission
Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 17:09

LONDON MARKET CLOSE: Stocks downbeat before central bank rate storm

(Alliance News) - Stocks in London closed in the red on Monday, as tech gains in New York failed to make an impact ahead of several interest rate decisions from central banks across the world this week.

Read more
18 Mar 2024 14:14

Faron shares jump on encouraging trial data

(Sharecast News) - Faron Pharmaceuticals announced further encouraging data from the first phase of its 'BEXMAB' trial on Monday, targeting higher-risk (HR) myelodysplastic syndrome (MDS) patients who had failed prior hypomethylating agent (HMA) treatment.

Read more
18 Mar 2024 11:41

Faron Pharmaceuticals shares jump on positive data from Bexmab study

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said a study showed more patients responding to treatment in a new readout of the Bexmab study focused on myelodysplastic syndrome, or MDS.

Read more
18 Mar 2024 10:05

AIM WINNERS & LOSERS: Clontarf raises GBP400,000; Faron jumps

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
13 Mar 2024 20:49

EARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
13 Mar 2024 11:52

Faron Pharmaceuticals reports year of clinical progress

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals reported a year of strong progress on Wednesday, with significant overall response rates seen in both previously hypomethylating agent (HMA)-failed and higher-risk myelodysplastic syndrome (MDS) patient populations in the phase one part of the BEXMAB study.

Read more
6 Mar 2024 16:06

UK earnings, trading statements calendar - next 7 days

Thursday 7 March 
Admiral Group PLCFull Year Results
Aviva PLCFull Year Results
Beazley PLCFull Year Results
Brooks Macdonald Group PLCHalf Year Results
Coats Group PLCFull Year Results
Darktrace PLCHalf Year Results
Elementis PLCFull Year Results
Entain PLCFull Year Results
Funding Circle Holdings PLCFull Year Results
Harbour Energy PLCFull Year Results
ITV PLCFull Year Results
Kier Group PLCFull Year Results
Melrose Industries PLCFull Year Results
Nexus Infrastructure PLCFull Year Results
PageGroup PLCFull Year Results
Physiomics PLCHalf Year Results
Rentokil Initial PLCFull Year Results
Robert Walters PLCFull Year Results
Spirax-Sarco Engineering PLCFull Year Results
TT Electronics PLCFull Year Results
Tyman PLCFull Year Results
Friday 8 March 
Informa PLCFull Year Results
Just Group PLCFull Year Results
LMS Capital PLCFull Year Results
Stelrad Group PLCFull Year Results
Monday 11 March 
HgCapital Trust PLCFull Year Results
Mincon Group PLCFull Year Results
MTI Wireless Edge LtdFull Year Results
Tuesday 12 March 
BATM Advanced Communications LtdFull Year Results
Costain Group PLCFull Year Results
Domino's Pizza Group PLCFull Year Results
Fonix Mobile PLCHalf Year Results
Foresight Solar Fund LtdFull Year Results
Genuit PLCFull Year Results
H&T Group PLCFull Year Results
Hill & Smith PLCFull Year Results
MaxCyte IncFull Year Results
Persimmon PLCFull Year Results
Synthomer PLCFull Year Results
Target Healthcare REIT PLCHalf Year Results
TI Fluid Systems PLCFull Year Results
TP ICAP Group PLCFull Year Results
Wednesday 13 March 
4imprint Group PLCFull Year Results
Advanced Medical Solutions Group PLCFull Year Results
Balfour Beatty PLCFull Year Results
Centaur Media PLCFull Year Results
Faron Pharmaceuticals LtdFull Year Results
Ferrexpo PLCFull Year Results
Gym Group PLCFull Year Results
Hochschild Mining PLCFull Year Results
IP Group PLCFull Year Results
Keywords Studios PLCFull Year Results
Kin & Carta PLCHalf Year Results
Metro Bank Holdings PLCFull Year Results
Nexteq PLCFull Year Results
PensionBee Group PLCFull Year Results
Public Policy Holding Co IncFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Supermarket Income REIT PLCHalf Year Results
Trainline PLCTrading Statement
Vaalco Energy IncFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.